They used a short-interfering ribonucleic acid (siRNA) to specifically silence an allele of RyR2 that bears a dominant negative (R4496C) mutation in the CPVT mouse model (Table 4). This evidence concerns the gene RYR2 and catecholaminergic polymorphic ventricular tachycardia.